---
title: "River Global Investors Discloses Investment in MaxCyte with 6.1% Stake"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286427947.md"
description: "River Global Investors LLP has disclosed a 6.095% stake in MaxCyte, Inc., following open-market purchases on May 13, 2026. The investment firm filed a Schedule 13D, indicating an active filing due to surpassing the 5% reporting threshold. River Global Investors acquired 650,000 shares at approximately $1.11 each, but has not announced any plans for board seats or mergers. The firm focuses on active equity strategies and manages pooled funds for institutional clients, seeking long-term value across global market capitalizations."
datetime: "2026-05-14T13:46:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286427947.md)
  - [en](https://longbridge.com/en/news/286427947.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286427947.md)
---

# River Global Investors Discloses Investment in MaxCyte with 6.1% Stake

River Global Investors LLP disclosed a 6.095% stake in MAXCYTE, INC. common stock. The firm filed a Schedule 13D on May 14, 2026, following open-market purchases on May 13, 2026. The position moves the London-based manager above the 5% reporting threshold, indicating an active filing rather than a passive 13G.

**Investor Intent**

River Global Investors bought the shares for funds it manages using investment capital, and it reported brokered open-market trades on May 13, 2026 totaling 650,000 shares at prices around $1.11 per share. The firm did not outline plans related to board seats, mergers, or other changes at MaxCyte.

**Investor's Background**

River Global Investors LLP is a London-based investment firm that manages pooled funds for institutional clients. The firm focuses on active equity strategies and seeks to build positions where it sees long-term value. It invests globally across market capitalizations with a research-driven approach.

Original SEC Filing: MAXCYTE, INC. \[ MXCT \] - SCHEDULE 13D - May. 14, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [MXCT.US](https://longbridge.com/en/quote/MXCT.US.md)

## Related News & Research

- [2 reasons not to chase Cerebras stock after its explosive IPO](https://longbridge.com/en/news/286579852.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [Bullish reports first quarter 2026 results | BLSH Stock News](https://longbridge.com/en/news/286402620.md)
- [Golar LNG Limited: 2026 AGM Results Notification | GLNG Stock News](https://longbridge.com/en/news/286963548.md)
- [Prairie Operating Co. Announces First Quarter 2026 Results and Reaffirms 2026 Guidance | PROP Stock News](https://longbridge.com/en/news/286463109.md)